Business Responsibility And Sustainability Report

Overview

The report covers FY 2023-24 sustainability disclosures for Orchid Pharma, including Board oversight, materiality prioritization, emissions, energy and waste data. It reports 339.9385083 metric tonnes of Scope 1 emissions and 41557.47901 metric tonnes of Scope 2 emissions. The report also describes energy-efficiency, water-reuse, solvent-recovery and zero-liquid-discharge initiatives.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Chapter
Fiscal year: 2023-2024
Period: Ends 31 March 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services